Search tips
Search criteria 


Logo of jrsocmedLink to Publisher's site
J R Soc Med. 2003; 96(Suppl 43): 2–10.
PMCID: PMC1308781

Atypical cystic fibrosis--diagnostic and management dilemmas.

Full Text

The Full Text of this article is available as a PDF (141K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Wallis C. Diagnosing cystic fibrosis: blood, sweat, and tears. Arch Dis Child. 1997 Feb;76(2):85–88. [PMC free article] [PubMed]
  • Davis PB, Drumm M, Konstan MW. Cystic fibrosis. Am J Respir Crit Care Med. 1996 Nov;154(5):1229–1256. [PubMed]
  • Littlewood JM. The sweat test. Arch Dis Child. 1986 Nov;61(11):1041–1043. [PMC free article] [PubMed]
  • Massie J, Robinson P. Cystic fibrosis: the twilight zone. Pediatr Pulmonol. 1999 Sep;28(3):222–224. [PubMed]
  • Knowles Michael R, Durie Peter R. What is cystic fibrosis? N Engl J Med. 2002 Aug 8;347(6):439–442. [PubMed]
  • Wilson DC, Ellis L, Zielenski J, Corey M, Ip WF, Tsui LC, Tullis E, Knowles MR, Durie PR. Uncertainty in the diagnosis of cystic fibrosis: possible role of in vivo nasal potential difference measurements. J Pediatr. 1998 Apr;132(4):596–599. [PubMed]
  • Goldstein JL, Shapiro AB, Rao MC, Layden TJ. In vivo evidence of altered chloride but not potassium secretion in cystic fibrosis rectal mucosa. Gastroenterology. 1991 Oct;101(4):1012–1019. [PubMed]
  • Rosenstein BJ, Cutting GR. The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel. J Pediatr. 1998 Apr;132(4):589–595. [PubMed]
  • Rosenstein Beryl J. Cystic fibrosis diagnosis: new dilemmas for an old disorder. Pediatr Pulmonol. 2002 Feb;33(2):83–84. [PubMed]
  • Welsh MJ, Smith AE. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell. 1993 Jul 2;73(7):1251–1254. [PubMed]
  • Zeitlin PL. Novel pharmacologic therapies for cystic fibrosis. J Clin Invest. 1999 Feb;103(4):447–452. [PMC free article] [PubMed]
  • Dörk T, Dworniczak B, Aulehla-Scholz C, Wieczorek D, Böhm I, Mayerova A, Seydewitz HH, Nieschlag E, Meschede D, Horst J, et al. Distinct spectrum of CFTR gene mutations in congenital absence of vas deferens. Hum Genet. 1997 Sep;100(3-4):365–377. [PubMed]
  • Dohle GR, Veeze HJ, Overbeek SE, van den Ouweland AM, Halley DJ, Weber RF, Niermeijer MF. The complex relationships between cystic fibrosis and congenital bilateral absence of the vas deferens: clinical, electrophysiological and genetic data. Hum Reprod. 1999 Feb;14(2):371–374. [PubMed]
  • Girodon E, Cazeneuve C, Lebargy F, Chinet T, Costes B, Ghanem N, Martin J, Lemay S, Scheid P, Housset B, et al. CFTR gene mutations in adults with disseminated bronchiectasis. Eur J Hum Genet. 1997 May-Jun;5(3):149–155. [PubMed]
  • Milla CE. Allergic bronchopulmonary aspergillosis and cystic fibrosis. Pediatr Pulmonol. 1999 Feb;27(2):71–73. [PubMed]
  • Miller PW, Hamosh A, Macek M, Jr, Greenberger PA, MacLean J, Walden SM, Slavin RG, Cutting GR. Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in allergic bronchopulmonary aspergillosis. Am J Hum Genet. 1996 Jul;59(1):45–51. [PubMed]
  • Choudari CP, Lehman GA, Sherman S. Pancreatitis and cystic fibrosis gene mutations. Gastroenterol Clin North Am. 1999 Sep;28(3):543–viii. [PubMed]
  • Sharer N, Schwarz M, Malone G, Howarth A, Painter J, Super M, Braganza J. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med. 1998 Sep 3;339(10):645–652. [PubMed]
  • Mekus F, Ballmann M, Bronsveld I, Dörk T, Bijman J, Tümmler B, Veeze HJ. Cystic-fibrosis-like disease unrelated to the cystic fibrosis transmembrane conductance regulator. Hum Genet. 1998 May;102(5):582–586. [PubMed]
  • Groman Joshua D, Meyer Michelle E, Wilmott Robert W, Zeitlin Pamela L, Cutting Garry R. Variant cystic fibrosis phenotypes in the absence of CFTR mutations. N Engl J Med. 2002 Aug 8;347(6):401–407. [PubMed]
  • Rozmahel R, Wilschanski M, Matin A, Plyte S, Oliver M, Auerbach W, Moore A, Forstner J, Durie P, Nadeau J, et al. Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor. Nat Genet. 1996 Mar;12(3):280–287. [PubMed]
  • Gan KH, Veeze HJ, van den Ouweland AM, Halley DJ, Scheffer H, van der Hout A, Overbeek SE, de Jongste JC, Bakker W, Heijerman HG. A cystic fibrosis mutation associated with mild lung disease. N Engl J Med. 1995 Jul 13;333(2):95–99. [PubMed]
  • Acton JD, Wilmott RW. Phenotype of CF and the effects of possible modifier genes. Paediatr Respir Rev. 2001 Dec;2(4):332–339. [PubMed]
  • Chu CS, Trapnell BC, Curristin S, Cutting GR, Crystal RG. Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA. Nat Genet. 1993 Feb;3(2):151–156. [PubMed]
  • Gan KH, Veeze HJ, van den Ouweland AM, Halley DJ, Scheffer H, van der Hout A, Overbeek SE, de Jongste JC, Bakker W, Heijerman HG. A cystic fibrosis mutation associated with mild lung disease. N Engl J Med. 1995 Jul 13;333(2):95–99. [PubMed]
  • Monaghan KG, Feldman GL, Barbarotto GM, Manji S, Desai TK, Snow K. Frequency and clinical significance of the S1235R mutation in the cystic fibrosis transmembrane conductance regulator gene: results from a collaborative study. Am J Med Genet. 2000 Dec 11;95(4):361–365. [PubMed]
  • Rohlfs EM, Shaheen NJ, Silverman LM. Is the hemochromatosis gene a modifier locus for cystic fibrosis? Genet Test. 1998;2(1):85–88. [PubMed]
  • Zielenski J, Corey M, Rozmahel R, Markiewicz D, Aznarez I, Casals T, Larriba S, Mercier B, Cutting GR, Krebsova A, et al. Detection of a cystic fibrosis modifier locus for meconium ileus on human chromosome 19q13. Nat Genet. 1999 Jun;22(2):128–129. [PubMed]
  • Hull J, Thomson AH. Contribution of genetic factors other than CFTR to disease severity in cystic fibrosis. Thorax. 1998 Dec;53(12):1018–1021. [PMC free article] [PubMed]
  • Garred P, Madsen HO, Hofmann B, Svejgaard A. Increased frequency of homozygosity of abnormal mannan-binding-protein alleles in patients with suspected immunodeficiency. Lancet. 1995 Oct 7;346(8980):941–943. [PubMed]
  • Taylor ME, Brickell PM, Craig RK, Summerfield JA. Structure and evolutionary origin of the gene encoding a human serum mannose-binding protein. Biochem J. 1989 Sep 15;262(3):763–771. [PubMed]
  • Garred P, Pressler T, Madsen HO, Frederiksen B, Svejgaard A, Høiby N, Schwartz M, Koch C. Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis. J Clin Invest. 1999 Aug;104(4):431–437. [PMC free article] [PubMed]
  • Mekus F, Ballmann M, Bronsveld I, Bijman J, Veeze H, Tümmler B. Categories of deltaF508 homozygous cystic fibrosis twin and sibling pairs with distinct phenotypic characteristics. Twin Res. 2000 Dec;3(4):277–293. [PubMed]
  • Abdul Wahab A, Al Thani G, Dawod ST, Kambouris M, Al Hamed M. Heterogeneity of the cystic fibrosis phenotype in a large kindred family in Qatar with cystic fibrosis mutation (I1234V). J Trop Pediatr. 2001 Apr;47(2):110–112. [PubMed]
  • Ranganathan SC, Dezateux C, Bush A, Carr SB, Castle RA, Madge S, Price J, Stroobant J, Wade A, Wallis C, et al. Airway function in infants newly diagnosed with cystic fibrosis. Lancet. 2001 Dec 8;358(9297):1964–1965. [PubMed]
  • Kosorok MR, Zeng L, West SE, Rock MJ, Splaingard ML, Laxova A, Green CG, Collins J, Farrell PM. Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition. Pediatr Pulmonol. 2001 Oct;32(4):277–287. [PubMed]
  • Hiatt PW, Grace SC, Kozinetz CA, Raboudi SH, Treece DG, Taber LH, Piedra PA. Effects of viral lower respiratory tract infection on lung function in infants with cystic fibrosis. Pediatrics. 1999 Mar;103(3):619–626. [PubMed]
  • Dodge JA. Nutritional requirements in cystic fibrosis: a review. J Pediatr Gastroenterol Nutr. 1988;7 (Suppl 1):S8–11. [PubMed]
  • Bell SC, Bowerman AR, Davies CA, Campbell IA, Shale DJ, Elborn JS. Nutrition in adults with cystic fibrosis. Clin Nutr. 1998 Oct;17(5):211–215. [PubMed]
  • Kerem E, Corey M, Kerem BS, Rommens J, Markiewicz D, Levison H, Tsui LC, Durie P. The relation between genotype and phenotype in cystic fibrosis--analysis of the most common mutation (delta F508). N Engl J Med. 1990 Nov 29;323(22):1517–1522. [PubMed]
  • Bush A, Wallis C. Time to think again: cystic fibrosis is not an "all or none" disease. Pediatr Pulmonol. 2000 Aug;30(2):139–144. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press